|Email Newsletters from Pharmaceutical Technology and Pharmaceutical Technology Europe|
News from Europe's pharmaceutical manufacturing industry coupled with upcoming events, and exclusive articles and interviews from industry experts.
Industry Briefs: Mar. 26, 2012
Corcept Therapeutics has selected PharmaForm as its primary commercial manufacturer for its newly approved drug product, Korlym (mifepristone) for treating Cushing’s syndrome. Read More
Coronado Biosciences has signed a collaboration agreement with Dr. Falk Pharma and OvaMed for the development of trichuris suis ova for treating Crohn’s Disease. Read More
Elite Pharmaceuticals has signed an agreement with a private Hong Kong-based company to develop a branded prescription pharmaceutical product in the US. Read More
GE Healthcare has expanded its Shanghai Fast Trak training center to serve the growing biopharmaceutical industry in China.
Impax and Tolmar have multiproduct agreement for the development, supply, and distribution of alternative dosage-form products. Read More
Marken has completed all commissioning work for its new operational hub in Feltham, United Kingdom. Read More
Adhesives Research appointed Steven Herbert to the position of manufacturing manager.
Albany Molecular Research has named Stephen Rossmeis senior manager to oversee the company's facilities at Burlington, Massachusetts aseptic-fill operations. Read More
Avrio Biopharmaceuticals has appointed William P. Botha as president. Read More